medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2025-6-13-20medalphabet-4337Research ArticleСтатьиОсобенности микробиоты кишечника при заболеваниях желчевыводящих путейFeatures of gut microbiota in diseases of the biliary tracthttps://orcid.org/0000-0002-7083-2692КотляровС. Н.KotlyarovS. N.

Котляров Станислав Николаевич, д. м. н., доцент, заведующий кафедрой сестринского дела,

г. Рязань.

Kotlyarov Stanislav N., DM Sci (habil.), Associate Professor, Head of Nursing Dept.,

Ryazan.

https://orcid.org/0000-0002-5872-1308ШелухинаС. В.SheloukhinaS. V.

Шелухина Светлана Витальевна, к. м. н., ассистент кафедры сестринского дела,

г. Рязань.

Sheloukhina Svetlana V., PhD Med, Assistant Professor at Nursing Dept.,

Ryazan.

https://orcid.org/0000-0002-6753-7828МарковаЕ. В.MarkovaE. V.

Маркова Елена Владимировна, к. м. н., ассистент кафедры сестринского дела,

г. Рязань.

Markova Elena V., PhD Med, Assistant Professor at Nursing Dept.,

Ryazan.

https://orcid.org/0000-0003-3402-1128БутовМ. А.ButovM. A.

Бутов Михаил Александрович, д. м. н., профессор, профессор кафедры сестринского дела, заслуженный врач Российской Федерации,

г. Рязань.

Butov Mikhail A., DM Sci (habil.), Professor, Professor at Nursing Dept, Honored Doctor of the Russian Federation,

Ryazan.

butov-m@yandex.ruhttps://orcid.org/0000-0002-4396-5051ВасилевскаяА. С.VasilevskayaA. S.

Василевская Анна Станиславовна, к. м. н., доцент кафедры сестринского дела,

г. Рязань.

Vasilevskaya Anna S., PhD Med, Associate Professor at Nursing Dept.,

Ryazan.

ФГБОУ ВО «Рязанский государственный медицинский университет имени академика И. П. Павлова» Минздрава РоссииРоссияRyazan State Medical University named after academician I. P. PavlovRussian Federation20252605202506«Гастроэнтерология и диетология» (1)1320Copyright © Котляров С.Н., Шелухина С.В., Маркова Е.В., Бутов М.А., Василевская А.С., 20252025Котляров С.Н., Шелухина С.В., Маркова Е.В., Бутов М.А., Василевская А.С.Kotlyarov S.N., Sheloukhina S.V., Markova E.V., Butov M.A., Vasilevskaya A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/4337

Цель исследования. Состав, метаболическая и иммунная активность микробиоты кишечника важны для нормального функционирования не только кишечника, но и других органов и систем.Материалы и методы. В настоящем обзоре проанализированы литературные данные о взаимосвязи микробиоты кишечника при заболеваниях желчевыводящих путей.Результаты и заключение. Изменения микробиоты кишечника могут вызывать не только изменения в системе органов пищеварения, но и влиять на состояние организма в целом.

The purpose of the study. The composition, metabolic and immune activity of the gut microbiota are important for the normal functioning not only of the intestine, but also of other organs and systems.Materials and methods. The present review analysed the literature data on the relationship of gut microbiota in biliary tract diseases.Results and conclusion. Changes in gut microbiota can cause not only changes in the system of digestive organs, but also affect the state of the organism as a whole.

микробиота кишечниказаболевания желчевыводящих путейиммунная системаметаболизмgut microbiotabiliary tract diseasesimmune systemmetabolismReferencesZhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, et al. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front Immunol. 2020; 11: 575.Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, et al. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Front Immunol. 2020; 11: 575.Ivashkin VT, Fomin VV, Tkacheva ON, Medvedev OS, Poluektova EA, Abdulganieva DI, et al. Small Intestinal Bacterial Overgrowth in Various Specialties of Medical Practice (Literature Review and Expert Council Resolution). Russ J Gastroenterol Hepatol Coloproctology. 2024 Feb 18; 34 (2): 14–34.Ivashkin VT, Fomin VV, Tkacheva ON, Medvedev OS, Poluektova EA, Abdulganieva DI, et al. Small Intestinal Bacterial Overgrowth in Various Specialties of Medical Practice (Literature Review and Expert Council Resolution). Russ J Gastroenterol Hepatol Coloproctology. 2024 Feb 18; 34 (2): 14–34.Zielińska M, Pawłowska A, Orzeł A, Sulej L, Muzyka-Placzyńska K, Baran A, et al. Wound Microbiota and Its Impact on Wound Healing. Int J Mol Sci. 2023 Dec 10; 24 (24): 17318.Zielińska M, Pawłowska A, Orzeł A, Sulej L, Muzyka-Placzyńska K, Baran A, et al. Wound Microbiota and Its Impact on Wound Healing. Int J Mol Sci. 2023 Dec 10; 24 (24): 17318.Dempsey E, Corr SC. Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Front Immunol. 2022 Apr 6; 13: 840245.Dempsey E, Corr SC. Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Front Immunol. 2022 Apr 6; 13: 840245.Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions. Microorganisms. 2020 Oct 15; 8 (10): 1587.Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions. Microorganisms. 2020 Oct 15; 8 (10): 1587.Elgamal Z, Singh P, Geraghty P. The Upper Airway Microbiota, Environmental Exposures, Inflammation, and Disease. Med Kaunas Lith. 2021 Aug 14; 57 (8): 823.Elgamal Z, Singh P, Geraghty P. The Upper Airway Microbiota, Environmental Exposures, Inflammation, and Disease. Med Kaunas Lith. 2021 Aug 14; 57 (8): 823.Kennedy MS, Chang EB. The microbiome: composition and locations. Prog Mol Biol Transl Sci. 2020; 176: 1–42.Kennedy MS, Chang EB. The microbiome: composition and locations. Prog Mol Biol Transl Sci. 2020; 176: 1–42.Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022 Apr 23; 7 (1): 135.Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022 Apr 23; 7 (1): 135.Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19; 14 (8): e1002533.Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19; 14 (8): e1002533.Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7; 27 (25): 3837–50.Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7; 27 (25): 3837–50.Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014 Sep; 38 (5): 996–1047.Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014 Sep; 38 (5): 996–1047.Jiao N, Ke X, Zhu L, Zhu R. Evidence challenging the causal role of gut microbiota in inflammatory bowel diseases. Gastroenterol Rep. 2023 Oct 11; 11: goad064.Jiao N, Ke X, Zhu L, Zhu R. Evidence challenging the causal role of gut microbiota in inflammatory bowel diseases. Gastroenterol Rep. 2023 Oct 11; 11: goad064.Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021 Jan; 18 (1): 4–17.Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021 Jan; 18 (1): 4–17.Athanasopoulou K, Adamopoulos PG, Scorilas A. Unveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics. Biomedicines. 2023 Mar 9; 11 (3): 827.Athanasopoulou K, Adamopoulos PG, Scorilas A. Unveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics. Biomedicines. 2023 Mar 9; 11 (3): 827.Wang Q, Hao C, Yao W, Zhu D, Lu H, Li L, et al. Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation. BMC Gastroenterol. 2020 Mar 6; 20 (1): 59.Wang Q, Hao C, Yao W, Zhu D, Lu H, Li L, et al. Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation. BMC Gastroenterol. 2020 Mar 6; 20 (1): 59.Lung microbiome: new insights into the pathogenesis of respiratory diseases | Signal Transduction and Targeted Therapy [Internet]. [cited 2025 Feb 6]. Available from: https://www.nature.com/articles/s41392-023-01722-yLung microbiome: new insights into the pathogenesis of respiratory diseases | Signal Transduction and Targeted Therapy [Internet]. [cited 2025 Feb 6]. Available from: https://www.nature.com/articles/s41392-023-01722-yde Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022 May; 71 (5): 1020–32.de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022 May; 71 (5): 1020–32.Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019 Jan 10; 7 (1): 14.Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019 Jan 10; 7 (1): 14.Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kołat D, et al. Critical role of the gut microbiota in immune responses and cancer immunotherapy. J Hematol OncolJ Hematol Oncol. 2024 May 14; 17 (1): 33.Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kołat D, et al. Critical role of the gut microbiota in immune responses and cancer immunotherapy. J Hematol OncolJ Hematol Oncol. 2024 May 14; 17 (1): 33.Vaga S, Lee S, Ji B, Andreasson A, Talley NJ, Agréus L, et al. Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals. Sci Rep. 2020 Sep 11; 10 (1): 14977.Vaga S, Lee S, Ji B, Andreasson A, Talley NJ, Agréus L, et al. Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals. Sci Rep. 2020 Sep 11; 10 (1): 14977.Juge N. Relationship between mucosa-associated gut microbiota and human diseases. Biochem Soc Trans. 2022 Oct 31; 50 (5): 1225–36.Juge N. Relationship between mucosa-associated gut microbiota and human diseases. Biochem Soc Trans. 2022 Oct 31; 50 (5): 1225–36.Wang J, Feng J, Zhu Y, Li D, Wang J, Chi W. Diversity and Biogeography of Human Oral Saliva Microbial Communities Revealed by the Earth Microbiome Project. Front Microbiol. 2022 Jun 13; 13: 931065.Wang J, Feng J, Zhu Y, Li D, Wang J, Chi W. Diversity and Biogeography of Human Oral Saliva Microbial Communities Revealed by the Earth Microbiome Project. Front Microbiol. 2022 Jun 13; 13: 931065.Baty JJ, Stoner SN, Scoffield JA. Oral Commensal Streptococci: Gatekeepers of the Oral Cavity. J Bacteriol. 204 (11): e00257-22.Baty JJ, Stoner SN, Scoffield JA. Oral Commensal Streptococci: Gatekeepers of the Oral Cavity. J Bacteriol. 204 (11): e00257-22.Wen J, Lau HCH, Peppelenbosch M, Yu J. Gastric Microbiota beyond H. pylori: An Emerging Critical Character in Gastric Carcinogenesis. Biomedicines. 2021 Nov 12; 9 (11): 1680.Wen J, Lau HCH, Peppelenbosch M, Yu J. Gastric Microbiota beyond H. pylori: An Emerging Critical Character in Gastric Carcinogenesis. Biomedicines. 2021 Nov 12; 9 (11): 1680.Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020 Mar; 51 (6): 582–602.Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020 Mar; 51 (6): 582–602.Ohno H, Satoh-Takayama N. Stomach microbiota, Helicobacter pylori, and group 2 innate lymphoid cells. Exp Mol Med. 2020 Sep; 52 (9): 1377–82.Ohno H, Satoh-Takayama N. Stomach microbiota, Helicobacter pylori, and group 2 innate lymphoid cells. Exp Mol Med. 2020 Sep; 52 (9): 1377–82.Kastl AJ, Terry NA, Wu GD, Albenberg LG. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cell Mol Gastroenterol Hepatol. 2019 Jul 22; 9 (1): 33–45.Kastl AJ, Terry NA, Wu GD, Albenberg LG. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cell Mol Gastroenterol Hepatol. 2019 Jul 22; 9 (1): 33–45.Jensen BAH, Heyndrickx M, Jonkers D, Mackie A, Millet S, Naghibi M, et al. Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration. Cell Rep Med. 2023 Sep 7; 4 (9): 101190.Jensen BAH, Heyndrickx M, Jonkers D, Mackie A, Millet S, Naghibi M, et al. Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration. Cell Rep Med. 2023 Sep 7; 4 (9): 101190.Michaudel C, Sokol H. The Gut Microbiota at the Service of Immunometabolism. Cell Metab. 2020 Oct 6; 32 (4): 514–23.Michaudel C, Sokol H. The Gut Microbiota at the Service of Immunometabolism. Cell Metab. 2020 Oct 6; 32 (4): 514–23.Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020 Dec; 113 (12): 2019–40.Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020 Dec; 113 (12): 2019–40.Bozomitu L, Miron I, Adam Raileanu A, Lupu A, Paduraru G, Marcu FM, et al. The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders. Biomedicines. 2022 Dec 2; 10 (12): 3117.Bozomitu L, Miron I, Adam Raileanu A, Lupu A, Paduraru G, Marcu FM, et al. The Gut Microbiome and Its Implication in the Mucosal Digestive Disorders. Biomedicines. 2022 Dec 2; 10 (12): 3117.Pracht K, Wittner J, Kagerer F, Jäck HM, Schuh W. The intestine: A highly dynamic microenvironment for IgA plasma cells. Front Immunol. 2023 Feb 16; 14: 1114348.Pracht K, Wittner J, Kagerer F, Jäck HM, Schuh W. The intestine: A highly dynamic microenvironment for IgA plasma cells. Front Immunol. 2023 Feb 16; 14: 1114348.Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, et al. Gut Microbiome– Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders. ACS Chem Neurosci. 2023 May 8; 14 (10): 1717–63.Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, et al. Gut Microbiome– Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders. ACS Chem Neurosci. 2023 May 8; 14 (10): 1717–63.Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res CR. 2021 Jan 25; 40 (1): 42.Ge Y, Wang X, Guo Y, Yan J, Abuduwaili A, Aximujiang K, et al. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res CR. 2021 Jan 25; 40 (1): 42.Caballero-Flores G, Pickard JM, Núñez G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat Rev Microbiol. 2023 Jun; 21 (6): 347–60.Caballero-Flores G, Pickard JM, Núñez G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat Rev Microbiol. 2023 Jun; 21 (6): 347–60.Nawaz N, Wen S, Wang F, Nawaz S, Raza J, Iftikhar M, et al. Lysozyme and Its Application as Antibacterial Agent in Food Industry. Molecules. 2022 Sep 24; 27 (19): 6305.Nawaz N, Wen S, Wang F, Nawaz S, Raza J, Iftikhar M, et al. Lysozyme and Its Application as Antibacterial Agent in Food Industry. Molecules. 2022 Sep 24; 27 (19): 6305.Larabi AB, Masson HLP, Bäumler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023; 15 (1): 2172671.Larabi AB, Masson HLP, Bäumler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023; 15 (1): 2172671.Fukumoto S, Tatewaki M, Yamada T, Fujimiya M, Mantyh C, Voss M, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol. 2003 May; 284 (5): R 1269–1276.Fukumoto S, Tatewaki M, Yamada T, Fujimiya M, Mantyh C, Voss M, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol. 2003 May; 284 (5): R 1269–1276.Drizaj E, Traini C, Vannucchi MG, Baccari MC. Nitric Oxide: From Gastric Motility to Gastric Dysmotility. Int J Mol Sci. 2021 Sep 16; 22 (18): 9990.Drizaj E, Traini C, Vannucchi MG, Baccari MC. Nitric Oxide: From Gastric Motility to Gastric Dysmotility. Int J Mol Sci. 2021 Sep 16; 22 (18): 9990.Nikolovska K, Seidler UE, Stock C. The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity. Front Physiol. 2022 May 18; 13: 899286.Nikolovska K, Seidler UE, Stock C. The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity. Front Physiol. 2022 May 18; 13: 899286.Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012 Feb; 22 (2): 292–8.Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012 Feb; 22 (2): 292–8.Salvi PS, Cowles RA. Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. Cells. 2021 Jul 14; 10 (7): 1775.Salvi PS, Cowles RA. Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. Cells. 2021 Jul 14; 10 (7): 1775.Uebanso T, Shimohata T, Mawatari K, Takahashi A. Functional Roles of B-Vitamins in the Gut and Gut Microbiome. Mol Nutr Food Res. 2020 Sep; 64 (18): e2000426.Uebanso T, Shimohata T, Mawatari K, Takahashi A. Functional Roles of B-Vitamins in the Gut and Gut Microbiome. Mol Nutr Food Res. 2020 Sep; 64 (18): e2000426.Tarracchini C, Lugli GA, Mancabelli L, van Sinderen D, Turroni F, Ventura M, et al. Exploring the vitamin biosynthesis landscape of the human gut microbiota. mSystems. 2024 Oct 22; 9 (10): e0092924.Tarracchini C, Lugli GA, Mancabelli L, van Sinderen D, Turroni F, Ventura M, et al. Exploring the vitamin biosynthesis landscape of the human gut microbiota. mSystems. 2024 Oct 22; 9 (10): e0092924.Marasco G, Cremon C, Barbaro MR, Falangone F, Montanari D, Capuani F, et al. Pathophysiology and Clinical Management of Bile Acid Diarrhea. J Clin Med. 2022 May 30; 11 (11): 3102.Marasco G, Cremon C, Barbaro MR, Falangone F, Montanari D, Capuani F, et al. Pathophysiology and Clinical Management of Bile Acid Diarrhea. J Clin Med. 2022 May 30; 11 (11): 3102.Markowiak-Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020 Apr 16; 12 (4): 1107.Markowiak-Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020 Apr 16; 12 (4): 1107.Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis. 2022 Jul 11; 13 (4): 1106–26.Liu J, Tan Y, Cheng H, Zhang D, Feng W, Peng C. Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives. Aging Dis. 2022 Jul 11; 13 (4): 1106–26.Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024; 19 (2): 275–93.Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024; 19 (2): 275–93.Notarbartolo V, Carta M, Accomando S, Giuffrè M. The First 1000 Days of Life: How Changes in the Microbiota Can Influence Food Allergy Onset in Children. Nutrients. 2023 Sep 16; 15 (18): 4014.Notarbartolo V, Carta M, Accomando S, Giuffrè M. The First 1000 Days of Life: How Changes in the Microbiota Can Influence Food Allergy Onset in Children. Nutrients. 2023 Sep 16; 15 (18): 4014.Nishida A, Nishino K, Ohno M, Sakai K, Owaki Y, Noda Y, et al. Update on gut microbiota in gastrointestinal diseases. World J Clin Cases. 2022 Aug 6; 10 (22): 7653–64.Nishida A, Nishino K, Ohno M, Sakai K, Owaki Y, Noda Y, et al. Update on gut microbiota in gastrointestinal diseases. World J Clin Cases. 2022 Aug 6; 10 (22): 7653–64.Villavicencio Kim J, Wu GY. Update on Sphincter of Oddi Dysfunction: A Review. J Clin Transl Hepatol. 2022 Jun 28; 10 (3): 515–21.Villavicencio Kim J, Wu GY. Update on Sphincter of Oddi Dysfunction: A Review. J Clin Transl Hepatol. 2022 Jun 28; 10 (3): 515–21.Corazziari E, Shaffer EA, Hogan WJ, Sherman S, Toouli J. Functional disorders of the biliary tract and pancreas. Gut. 1999 Sep; 45 (Suppl 2): II48–54.Corazziari E, Shaffer EA, Hogan WJ, Sherman S, Toouli J. Functional disorders of the biliary tract and pancreas. Gut. 1999 Sep; 45 (Suppl 2): II48–54.Simon DA, Friesen CA, Schurman JV, Colombo JM. Biliary Dyskinesia in Children and Adolescents: A Mini Review. Front Pediatr. 2020 Mar 24; 8: 122.Simon DA, Friesen CA, Schurman JV, Colombo JM. Biliary Dyskinesia in Children and Adolescents: A Mini Review. Front Pediatr. 2020 Mar 24; 8: 122.Kegnæs M, Novovic S, Shabanzadeh DM. Dysfunction of Biliary Sphincter of Oddi – Clinical, Diagnostic and Treatment Challenges. J Clin Med. 2023 Jul 20; 12 (14): 4802.Kegnæs M, Novovic S, Shabanzadeh DM. Dysfunction of Biliary Sphincter of Oddi – Clinical, Diagnostic and Treatment Challenges. J Clin Med. 2023 Jul 20; 12 (14): 4802.Georgescu D, Ionita I, Lascu A, Hut EF, Dragan S, Ancusa OE, et al. Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. Int J Gen Med. 2022; 15: 5513–31.Georgescu D, Ionita I, Lascu A, Hut EF, Dragan S, Ancusa OE, et al. Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. Int J Gen Med. 2022; 15: 5513–31.Kazi FN, Ghosh S, Sharma JVP, Saravanan S, Patil S. Trends in Gallbladder Disease in Young Adults: A Growing Concern. Cureus. 14 (8): e28555.Kazi FN, Ghosh S, Sharma JVP, Saravanan S, Patil S. Trends in Gallbladder Disease in Young Adults: A Growing Concern. Cureus. 14 (8): e28555.Porges SW, Furman SA. The Early Development of the Autonomic Nervous System Provides a Neural Platform for Social Behavior: A Polyvagal Perspective. Infant Child Dev. 2011 Feb; 20 (1): 106–18.Porges SW, Furman SA. The Early Development of the Autonomic Nervous System Provides a Neural Platform for Social Behavior: A Polyvagal Perspective. Infant Child Dev. 2011 Feb; 20 (1): 106–18.Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic Nervous System Dysfunction. J Am Coll Cardiol. 2019 Mar 19; 73 (10): 1189–206.Goldberger JJ, Arora R, Buckley U, Shivkumar K. Autonomic Nervous System Dysfunction. J Am Coll Cardiol. 2019 Mar 19; 73 (10): 1189–206.Futagami S, Yamawaki H, Agawa S, Higuchi K, Ikeda G, Noda H, et al. New classification Rome IV functional dyspepsia and subtypes. Transl Gastroenterol Hepatol. 2018 Sep 19; 3: 70.Futagami S, Yamawaki H, Agawa S, Higuchi K, Ikeda G, Noda H, et al. New classification Rome IV functional dyspepsia and subtypes. Transl Gastroenterol Hepatol. 2018 Sep 19; 3: 70.Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of oddi disorders. Gastroenterology. 2006 Apr; 130 (5): 1498–509.Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of oddi disorders. Gastroenterology. 2006 Apr; 130 (5): 1498–509.Dan WY, Yang YS, Peng LH, Sun G, Wang ZK. Gastrointestinal microbiome and cholelithiasis: Current status and perspectives. World J Gastroenterol. 2023 Mar 14; 29 (10): 1589–601.Dan WY, Yang YS, Peng LH, Sun G, Wang ZK. Gastrointestinal microbiome and cholelithiasis: Current status and perspectives. World J Gastroenterol. 2023 Mar 14; 29 (10): 1589–601.Grigor’eva I, Romanova T, Naumova N, Alikina T, Kuznetsov A, Kabilov M. Gut Microbiome in a Russian Cohort of Pre- and Post-Cholecystectomy Female Patients. J Pers Med. 2021 Apr 12; 11 (4): 294.Grigor’eva I, Romanova T, Naumova N, Alikina T, Kuznetsov A, Kabilov M. Gut Microbiome in a Russian Cohort of Pre- and Post-Cholecystectomy Female Patients. J Pers Med. 2021 Apr 12; 11 (4): 294.Liu L, Zhao Z, Hou X, Wu J. Effect of sphincter of Oddi dysfunction on the abundance of biliary microbiota (biliary microecology) in patients with common bile duct stones. Front Cell Infect Microbiol. 2022; 12: 1001441.Liu L, Zhao Z, Hou X, Wu J. Effect of sphincter of Oddi dysfunction on the abundance of biliary microbiota (biliary microecology) in patients with common bile duct stones. Front Cell Infect Microbiol. 2022; 12: 1001441.Menon S, Holt A, Farmer AD. Intra-sphincteric botulinum toxin in the management of functional biliary pain. Endosc Int Open. 2022 Apr; 10 (4): E 521–7.Menon S, Holt A, Farmer AD. Intra-sphincteric botulinum toxin in the management of functional biliary pain. Endosc Int Open. 2022 Apr; 10 (4): E 521–7.Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. Bile Acid Receptors and Gastrointestinal Functions. Liver Res. 2019 Mar; 3 (1): 31–9.Ticho AL, Malhotra P, Dudeja PK, Gill RK, Alrefai WA. Bile Acid Receptors and Gastrointestinal Functions. Liver Res. 2019 Mar; 3 (1): 31–9.Fan Y, Xu C, Xie L, Wang Y, Zhu S, An J, et al. Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation. Front Cell Infect Microbiol. 2022; 12: 956528.Fan Y, Xu C, Xie L, Wang Y, Zhu S, An J, et al. Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation. Front Cell Infect Microbiol. 2022; 12: 956528.Guo X, Okpara ES, Hu W, Yan C, Wang Y, Liang Q, et al. Interactive Relationships between Intestinal Flora and Bile Acids. Int J Mol Sci. 2022 Jul 28; 23 (15): 8343.Guo X, Okpara ES, Hu W, Yan C, Wang Y, Liang Q, et al. Interactive Relationships between Intestinal Flora and Bile Acids. Int J Mol Sci. 2022 Jul 28; 23 (15): 8343.Li J, Zhang R, Ma J, Tang S, Li Y, Li Y, et al. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth. Front Microbiol. 2021; 12: 710940.Li J, Zhang R, Ma J, Tang S, Li Y, Li Y, et al. Mucosa-Associated Microbial Profile Is Altered in Small Intestinal Bacterial Overgrowth. Front Microbiol. 2021; 12: 710940.Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry. 2020; 11: 664.Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry. 2020; 11: 664.Leite G, Morales W, Weitsman S, Celly S, Parodi G, Mathur R, et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. PLoS ONE. 2020 Jul 9; 15 (7): e0234906.Leite G, Morales W, Weitsman S, Celly S, Parodi G, Mathur R, et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. PLoS ONE. 2020 Jul 9; 15 (7): e0234906.Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013 Sep; 4 (5): 223–31.Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013 Sep; 4 (5): 223–31.Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, et al. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023 Jun 14; 29 (22): 3400–21.Efremova I, Maslennikov R, Poluektova E, Vasilieva E, Zharikov Y, Suslov A, et al. Epidemiology of small intestinal bacterial overgrowth. World J Gastroenterol. 2023 Jun 14; 29 (22): 3400–21.Funch-Jensen P, Drewes AM, Madácsy L. Evaluation of the biliary tract in patients with functional biliary symptoms. World J Gastroenterol WJG. 2006 May 14; 12 (18): 2839–45.Funch-Jensen P, Drewes AM, Madácsy L. Evaluation of the biliary tract in patients with functional biliary symptoms. World J Gastroenterol WJG. 2006 May 14; 12 (18): 2839–45.Ghosh G, Jesudian AB. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. J Clin Exp Hepatol. 2019; 9 (2): 257–67.Ghosh G, Jesudian AB. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. J Clin Exp Hepatol. 2019; 9 (2): 257–67.Shi X, Chen Z, Yang Y, Yan S. Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management. Gastroenterol Res Pract. 2022 Sep 12; 2022: 2642551.Shi X, Chen Z, Yang Y, Yan S. Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management. Gastroenterol Res Pract. 2022 Sep 12; 2022: 2642551.Taşcı EK, Karakoyun M, Sezak M, Doğanavsargil B, Çetin F, Aydoğdu S. Does bile reflux reduce Helicobacter pylori gastritis? Turk J Pediatr. 2022; 64 (1): 122–6.Taşcı EK, Karakoyun M, Sezak M, Doğanavsargil B, Çetin F, Aydoğdu S. Does bile reflux reduce Helicobacter pylori gastritis? Turk J Pediatr. 2022; 64 (1): 122–6.Han J, Wu S, Fan Y, Tian Y, Kong J. Biliary Microbiota in Choledocholithiasis and Correlation With Duodenal Microbiota. Front Cell Infect Microbiol. 2021; 11: 625589.Han J, Wu S, Fan Y, Tian Y, Kong J. Biliary Microbiota in Choledocholithiasis and Correlation With Duodenal Microbiota. Front Cell Infect Microbiol. 2021; 11: 625589.Lyu Z, Yu T, Zhang L, Xu X, Zhang Y, Li J, et al. Analysis of the relationship between bile duct and duodenal microbiota reveals that potential dysbacteriosis is the main cause of primary common bile duct stones. Synth Syst Biotechnol. 2021 Dec; 6 (4): 414–28.Lyu Z, Yu T, Zhang L, Xu X, Zhang Y, Li J, et al. Analysis of the relationship between bile duct and duodenal microbiota reveals that potential dysbacteriosis is the main cause of primary common bile duct stones. Synth Syst Biotechnol. 2021 Dec; 6 (4): 414–28.Ye C, Zhou W, Zhang H, Miao L, Lv G. Alterations of the Bile Microbiome in Recurrent Common Bile Duct Stone. BioMed Res Int. 2020; 2020: 4637560.Ye C, Zhou W, Zhang H, Miao L, Lv G. Alterations of the Bile Microbiome in Recurrent Common Bile Duct Stone. BioMed Res Int. 2020; 2020: 4637560.Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scand J Gastroenterol. 2019 Dec; 54 (12): 1419–25.Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance. Scand J Gastroenterol. 2019 Dec; 54 (12): 1419–25.Lee SM, Kim N, Yoon H, Kim YS, Choi SI, Park JH, et al. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients. Gut Liver. 2021 Mar 15; 15 (2): 253–61.Lee SM, Kim N, Yoon H, Kim YS, Choi SI, Park JH, et al. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients. Gut Liver. 2021 Mar 15; 15 (2): 253–61.Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, et al. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology. 2017 Jan; 152 (1): 111–123.e8.Tap J, Derrien M, Törnblom H, Brazeilles R, Cools-Portier S, Doré J, et al. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology. 2017 Jan; 152 (1): 111–123.e8.Ramos Meyers G, Samouda H, Bohn T. Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability. Nutrients. 2022 Dec 16; 14 (24): 5361.Ramos Meyers G, Samouda H, Bohn T. Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability. Nutrients. 2022 Dec 16; 14 (24): 5361.Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther. 2018; 35 (3): 289–310.Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther. 2018; 35 (3): 289–310.Olvera-Rosales LB, Cruz-Guerrero AE, Ramírez-Moreno E, Quintero-Lira A, Contreras-López E, Jaimez-Ordaz J, et al. Impact of the Gut Microbiota Balance on the Health–Disease Relationship: The Importance of Consuming Probiotics and Prebiotics. Foods. 2021 Jun 2; 10 (6): 1261.Olvera-Rosales LB, Cruz-Guerrero AE, Ramírez-Moreno E, Quintero-Lira A, Contreras-López E, Jaimez-Ordaz J, et al. Impact of the Gut Microbiota Balance on the Health–Disease Relationship: The Importance of Consuming Probiotics and Prebiotics. Foods. 2021 Jun 2; 10 (6): 1261.Shi Q, Yuan X, Zeng Y, Wang J, Zhang Y, Xue C, et al. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. Nutrients. 2023 May 22; 15 (10): 2411.Shi Q, Yuan X, Zeng Y, Wang J, Zhang Y, Xue C, et al. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. Nutrients. 2023 May 22; 15 (10): 2411.Binda C, Gibiino G, Coluccio C, Sbrancia M, Dajti E, Sinagra E, et al. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms. 2022 Jan 28; 10 (2): 312.Binda C, Gibiino G, Coluccio C, Sbrancia M, Dajti E, Sinagra E, et al. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Microorganisms. 2022 Jan 28; 10 (2): 312.Roszkowska P, Klimczak E, Ostrycharz E, Rączka A, Wojciechowska-Koszko I, Dybus A, et al. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge. Biomedicines. 2024 May 7; 12 (5): 1030.Roszkowska P, Klimczak E, Ostrycharz E, Rączka A, Wojciechowska-Koszko I, Dybus A, et al. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases-Current State of Knowledge. Biomedicines. 2024 May 7; 12 (5): 1030.Montoro-Huguet MA, Belloc B, Domínguez-Cajal M. Small and Large Intestine (I): Malabsorption of Nutrients. Nutrients. 2021 Apr 11; 13 (4): 1254.Montoro-Huguet MA, Belloc B, Domínguez-Cajal M. Small and Large Intestine (I): Malabsorption of Nutrients. Nutrients. 2021 Apr 11; 13 (4): 1254.Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 12 (1): 1782157.Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 12 (1): 1782157.Fitriakusumah Y, Lesmana CRA, Bastian WP, Jasirwan COM, Hasan I, Simadibrata M, et al. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. BMC Gastroenterol. 2019 Mar 20; 19: 43.Fitriakusumah Y, Lesmana CRA, Bastian WP, Jasirwan COM, Hasan I, Simadibrata M, et al. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience. BMC Gastroenterol. 2019 Mar 20; 19: 43.Anand S, Mande SS. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. NPJ Biofilms Microbiomes. 2022 Nov 1; 8 (1): 89.Anand S, Mande SS. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. NPJ Biofilms Microbiomes. 2022 Nov 1; 8 (1): 89.Liu P, Jin M, Hu P, Sun W, Tang Y, Wu J, et al. Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease. Curr Res Microb Sci. 2024; 7: 100315.Liu P, Jin M, Hu P, Sun W, Tang Y, Wu J, et al. Gut microbiota and bile acids: Metabolic interactions and impacts on diabetic kidney disease. Curr Res Microb Sci. 2024; 7: 100315.Jia M, Fan Y, Ma Q, Yang D, Wang Y, He X, et al. Gut microbiota dysbiosis promotes cognitive impairment via bile acid metabolism in major depressive disorder. Transl Psychiatry. 2024 Dec 24; 14 (1): 503.Jia M, Fan Y, Ma Q, Yang D, Wang Y, He X, et al. Gut microbiota dysbiosis promotes cognitive impairment via bile acid metabolism in major depressive disorder. Transl Psychiatry. 2024 Dec 24; 14 (1): 503.Salimi A, Sepehr A, Ajdarkosh H, Aghamohammad S, Talebi M, Rohani M, et al. Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease. Iran Biomed J. 2022 Sep; 26 (5): 350–6.Salimi A, Sepehr A, Ajdarkosh H, Aghamohammad S, Talebi M, Rohani M, et al. Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease. Iran Biomed J. 2022 Sep; 26 (5): 350–6.Kumar A, Pramanik J, Goyal N, Chauhan D, Sivamaruthi BS, Prajapati BG, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals. 2023 Apr 9; 16 (4): 565.Kumar A, Pramanik J, Goyal N, Chauhan D, Sivamaruthi BS, Prajapati BG, et al. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals. 2023 Apr 9; 16 (4): 565.Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression – A systematic review. Clin Psychol Rev. 2021 Feb; 83: 101943.Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression – A systematic review. Clin Psychol Rev. 2021 Feb; 83: 101943.You W, Zhu Y, Wei A, Du J, Wang Y, Zheng P, et al. Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile. J Neurotrauma. 2022 Jan; 39 (1–2): 227–37.You W, Zhu Y, Wei A, Du J, Wang Y, Zheng P, et al. Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile. J Neurotrauma. 2022 Jan; 39 (1–2): 227–37.Raygoza Garay JA, Turpin W, Lee SH, Smith MI, Goethel A, Griffiths AM, et al. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives. Gastroenterology. 2023 Sep; 165 (3): 670–81.Raygoza Garay JA, Turpin W, Lee SH, Smith MI, Goethel A, Griffiths AM, et al. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives. Gastroenterology. 2023 Sep; 165 (3): 670–81.Жиленко В. Ю. Исследование резистентности молочнокислых бактерий с пробиотическими свойствами / В. Ю. Жиленко, О. В. Куприян // Рациональное использование природных ресурсов и переработка техногенного сырья: фундаментальные проблемы науки, материаловедение, химия и биотехнология: Материалы Международной научной конференции, Алушта-Белгород, 30 мая – 03июня 2022 года. Белгород: Белгородский государственный технологический университет им. В. Г. Шухова, 2022.С. 401–405. – EDN DFVNJR.Zhilenko V. Yu. Study of resistance of lactic acid bacteria with probiotic properties / V. Yu. Zhilenko, O. V. Kupriyan. Rational use of natural resources and processing of technogenic raw materials: fundamental problems of science, materials science, chemistry and biotechnology: Proceedings of the International Scientific Conference, Alushta-Belgorod, May 30 - June 03, 2022. Belgorod: Belgorod State Technological University named after V. G. Shukhov, 2022. P. 401-405. (In Russ.). EDN DFVNJR.Славко Е. А. Применение синбиотиков в комплексной терапии заболеваний с синдромом избыточного бактериального роста. Е. А. Славко, А. Е. Желдыбаева. Лечение и профилактика. 2022; 12 (4): 85–89. EDN ADDZAH.Slavko E. A. Use of synbiotics in the complex therapy of diseases with bacterial overgrowth syndrome. E. A. Slavko, A. E. Zheldybaeva. Treatment and prevention. 2022; 12 (4): 85-89. (In Russ.). EDN ADDZAH.Трухан Д. И., Викторова И. А., Иванова Д. С. Синдром диареи в реальной клинической практике: актуальные аспекты дифференциальной диагностики и коррекции. Терапия. 2020; 2: 145–155. dhttps://dx.doi.org/10.18565/therapy.2020.2.145–155.Trukhan D. I., Viktorova I. A., Ivanova D. S. Diarrhea syndrome in real clinical practice: current aspects of differential diagnosis and correction. Therapy. 2020; 2: 145-155. (In Russ.). https://dx.doi.org/10.18565/therapy.2020.2.145–155Ардатская М. Д., Анучкин А. А., Буторова Л. И., Павлов А. И., Нугаева Н. Р., Фадина Ж. В. Патогенетические аспекты развития и лечения антибиотик-ассоциированной диареи: выбор синбиотика с позиции доказательной медицины. Медицинский совет. 2023; 17 (6): 113–125. https://doi.org/10.21518/ms2023–026Ardatskaya M.D., Anuchkin A.A., Butorova L.I., Pavlov A.I., Nugaeva N.R., FadinaZh.V.Pathogenetic aspects of the development and treatment of antibiotic-associated diarrhea: the choice of a synbiotic from the standpoint of evidence-based medicine. Medical Council. 2023; 17 (6): 113–125. (In Russ.). https://doi.org/10.21518/ms2023-026Rijkers G. T., Bengmark S., Enck P., Haller D., Herz U., Kalliomaki M. et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr. 2010; 140 (3): 671S–676S. https://doi.org/10.3945/jn.109.113779Rijkers G. T., Bengmark S., Enck P., Haller D., Herz U., Kalliomaki M. et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr. 2010; 140 (3): 671S–676S. https://doi.org/10.3945/jn.109.113779

The authors declare that there are no conflicts of interest present.